HMPV cases in India: Understanding its lesser-known impact on eye health
HMPV, also known as Human Metapneumovirus, is a virus that causes symptoms similar to cold. Cases of HMPV have been detected ...
Multiple Sclerosis News Today4d
OCS-05 shows safety, aids vision with optic neuritis in Phase 2 trial
OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...
Pharmabiz6d
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints: Zug, Switzerland Tuesday, January 7, 202 ...
Oculis price target raised to $31 from $23 at BofA
BofA raised the firm’s price target on Oculis (OCS) to $31 from $23 and keeps a Buy rating on the shares. The company reported Phase 2 results ...
BioWorld6d
Oculis presents 'groundbreaking' data in optic neuritis with OCS-05
Ophthalmic diseases specialist Oculis Holding AG announced positive phase II data showing its serum-glucose corticoid ...
Oculis Trial Shows Potential for Optical Neuroprotective Therapy
By Karen Roman Oculis Holding AG (Nasdaq: OCS) said Phase 2 of its neuroprotective candidate OCS-05 met key endpoints of ...
Oculis Holding’s OCS-05 Shows Promising Results in Phase 2 Trial for Acute Optic Neuritis
Oculis Holding ( (OCS) ) has issued an update. Oculis Holding has announced positive results from a Phase 2 trial for OCS-05, a potential first-in-class neuroprotective therapy for acute optic ...
Hosted on MSN6d
Oculis’ acute optic neuritis therapy trial meets primary endpoint
The trial is designed to assess the tolerability, efficacy, and safety of two different dosages of the therapy.
BioWorld6d
Oculis Holding’s OCS-05 improves vision function in phase II
Ophthalmic diseases specialist Oculis Holding AG announced positive phase II data showing its serum-glucose corticoid kinase-2 activator OCS-05 protected nerve cells and improved vision in patients ...